Acoustic neuroma screening: Difference between revisions
No edit summary |
Simrat Sarai (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Acoustic neuroma}} | {{Acoustic neuroma}} | ||
{{CMG}}{{AE}}{{Simrat}} | |||
==Overview== | |||
According to the USPTF, screening for acoustic neuroma is not recommended. | |||
==Screening== | |||
According to the USPTF, screening for acoustic neuroma is not recommended. Evaluation for NF-2 should be done in individuals with an apparently sporadic vestibular schwannoma occurring at less than 30 years of age, or a spinal tumor or meningioma occurring at less than 20 years of age.<ref name="pmid17470137">{{cite journal| author=Evans DG, Ramsden RT, Gokhale C, Bowers N, Huson SM, Wallace A| title=Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma? | journal=Clin Genet | year= 2007 | volume= 71 | issue= 4 | pages= 354-8 | pmid=17470137 | doi=10.1111/j.1399-0004.2007.00778.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17470137 }} </ref> Annual hearing screening with BAER (Brain stem auditory evoked response test), with referral to an audiologist for amplification, or speech therapy is recommended in patients with NF-2. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 05:29, 2 October 2015
|
Acoustic neuroma Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Acoustic neuroma screening On the Web | |
|
American Roentgen Ray Society Images of Acoustic neuroma screening | |
|
Risk calculators and risk factors for Acoustic neuroma screening | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
According to the USPTF, screening for acoustic neuroma is not recommended.
Screening
According to the USPTF, screening for acoustic neuroma is not recommended. Evaluation for NF-2 should be done in individuals with an apparently sporadic vestibular schwannoma occurring at less than 30 years of age, or a spinal tumor or meningioma occurring at less than 20 years of age.[1] Annual hearing screening with BAER (Brain stem auditory evoked response test), with referral to an audiologist for amplification, or speech therapy is recommended in patients with NF-2.
References
- ↑ Evans DG, Ramsden RT, Gokhale C, Bowers N, Huson SM, Wallace A (2007). "Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?". Clin Genet. 71 (4): 354–8. doi:10.1111/j.1399-0004.2007.00778.x. PMID 17470137.